BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18296707)

  • 21. C-reactive protein and vascular disease.
    Magadle R; Weiner P; Sotzkover A; Berar-Yanay N
    Isr Med Assoc J; 2001 Jan; 3(1):50-2. PubMed ID: 11344805
    [No Abstract]   [Full Text] [Related]  

  • 22. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples.
    Anderstam B; Ann-Christin BH; Valli A; Stenvinkel P; Lindholm B; Suliman ME
    Clin Chim Acta; 2008 Jul; 393(2):114-8. PubMed ID: 18423381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease.
    Ueno T; Watanabe H; Fukuda N; Tsunemi A; Tahira K; Matsumoto T; Takayama T; Chiku M; Saito S; Sato Y; Hirayama A; Matsumoto K; Soma M
    Med Sci Monit; 2009 Jul; 15(7):CR341-8. PubMed ID: 19564823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiovascular risk markers in schoolchildren from five provinces of eastern Colombia].
    Villarreal E; Forero Y; Poveda E; Baracaldo C; López E
    Biomedica; 2008 Mar; 28(1):38-49. PubMed ID: 18645660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
    Ballard PL; Truog WE; Merrill JD; Gow A; Posencheg M; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2008 Mar; 121(3):555-61. PubMed ID: 18310205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients.
    Bankier B; Barajas J; Martinez-Rumayor A; Januzzi JL
    J Psychosom Res; 2009 Mar; 66(3):189-94. PubMed ID: 19232230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: "plasma urate and risk of Parkinson's disease".
    Wise BL; Neogi T; Zhang Y
    Am J Epidemiol; 2008 Mar; 167(6):752-3; author reply 753-4. PubMed ID: 18283033
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of stress on markers of cardiovascular health.
    Smolin B; Leiba R; Levy Y
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):e15-7. PubMed ID: 17449232
    [No Abstract]   [Full Text] [Related]  

  • 32. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein.
    Ahonen TM; Kautiainen HJ; Keinänen-Kiukaanniemi SM; Kumpusalo EA; Vanhala MJ
    Am J Prev Med; 2008 Dec; 35(6):598-601. PubMed ID: 18842390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commentary: Social class, C-reactive protein and coronary heart disease.
    Casas JP
    Int J Epidemiol; 2008 Apr; 37(2):299-300. PubMed ID: 18285367
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender.
    Cavalca V; Veglia F; Squellerio I; Marenzi G; Minardi F; De Metrio M; Cighetti G; Boccotti L; Ravagnani P; Tremoli E
    Eur J Clin Invest; 2009 Apr; 39(4):267-72. PubMed ID: 19292881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased oxidative stress in hemodialysis patients with high risk for sleep apnea syndrome.
    Lim PS; Chen WC; Wu MY; Hu CY; Chien PI
    Blood Purif; 2009; 28(2):144-9. PubMed ID: 19590181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation.
    Plüss CE; Karlsson MR; Wallen N; Billing E; Held C
    Clin Rehabil; 2008 Apr; 22(4):306-18. PubMed ID: 18390974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation: another potential mechanism between diabetes mellitus and atrial fibrillation.
    Liu T; Li G
    Am J Cardiol; 2008 Jun; 101(11):1681-2. PubMed ID: 18489956
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.